Test Directory
| Test Code | ||||
| SJO | ||||
| Test Name | ||||
| Sjogren's Autoantibody Profile | ||||
| CPT Codes | ||||
| 86235 X 2 | ||||
| Included Tests | ||||
|
||||
| Expected Turnaround Time | ||||
| 4 - 7 days | ||||
| Clinical Utility | ||||
|
This panel is used to aid the diagnosis of Sjogren's Syndrome. One or both of the autoantibodies are detected in 80-90% of Sjogren's Syndrome (SS) and 30 - 35% of patients with Systemic Lupus erythematosus (SLE). SSA and SSB antibodies detected in 96% of patients with primary (SS) and in all patients with SS secondary to Rheumatoid Arthritis (RA). SSA and SSB are rarely detected in SS secondary to RA, progressive systemic sclerosis, and primary biliary cirrhosis. |
||||
| Specimen and Container Info | ||||
|
Preferred Specimen Type: Serum Desired Specimen Volume: 2 mL Preferred Collection Container: Gold Top, Serum Separator |
||||
| Processing and Submission Instructions | ||||
|
Separator tubes: Contains clot activator and gel for separating serum from cells, but not anticoagulant. Separate serum from cells as soon as the clot has formed (30 minutes). If specimen is centrifuged before clotting is complete, a fibrin clot will form on top of the cell. This may cause the gel barrier to not be intact and could cause improper separation of serum and cells, possibly affecting test results. |
||||
| Transport Instructions | ||||
|
Transport refrigerated. |
||||
| Stability Requirements | ||||
|
||||
| Methodology | ||||
| Semi-Quantitative Multiplex Bead Assay | ||||
| Reference Intervals | ||||
|
<1.0 AI, Negative |
||||
| Performing Location | ||||
| Roble Road Core Laboratory | ||||
| Testing Schedule | ||||
| Routine, Monday - Friday no holidays | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.